Company Profile
Rhino Therapeutics Limited
14604755•Private Limited With Share Capital
Get Full Access
19/01/2023
3 years
4
2
72110
low risk
Company Overview
Registration, classification & business activity
Rhino Therapeutics Limited (14604755) is a private limited with share capital incorporated on 19/01/2023 (3 years old) and registered in cheltenham, GL503PR. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Financial Overview
£1.58M
£798.9K
£785.0K
£2.61M
£745.2K
Key Metrics
2
Employees
4
Directors
1
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £464778.0 for Rhino Therapeutics: Pre-Clinical Model Development And Efficacy Testing Of The First Disease-Modifying Therapy Globally To Restore Sensorineural Olfactory Loss And Improve Patient Outcomes And Quality Of Life. The project started on 01/06/2025 and ended on 30/04/2026.
Import / Export
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating